Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic (GlobeNewswire) - Mar 25, 2024 - "Plus Therapeutics, Inc...announced it has successfully completed key validation testing and implementation of its tumor cell enumeration assay, known as CSF-01, to be used initially as an exploratory endpoint in its ReSPECT-LM clinical trials."
Diagnostic • CNS Tumor • Oncology • Solid Tumor
|